The Value of Specifying Brand-name Antiepileptic Drugs

被引：0
|
作者：
Ng, Yu-tze [1 ]
机构：
[1] St Josephs Med Hlth Ctr, Barrow Neurol Inst, Div Pediat Neurol, Phoenix, AZ 85013 USA
来源：
ARCHIVES OF NEUROLOGY | 2009年 / 66卷 / 11期
关键词：
GENERIC SUBSTITUTION; LAMOTRIGINE; EPILEPSY; CONSEQUENCES;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1415 / 1416
页数：2
相关论文
共 50 条
  • [41] Novelty of Active Ingredients in High-Cost Brand-Name Drugs
    Jung, Emily H.
    Sarpatwari, Ameet
    Kesselheim, Aaron S.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (07) : 2219 - 2221
  • [42] Are HMO physicians more price sensitive in prescribing brand-name drugs?
    Rice, Jennifer L.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND HEALTHCARE MARKETING, 2009, 3 (03) : 184 - 209
  • [43] Registered Randomized Trials Comparing Generic and Brand-Name Drugs: A Survey
    Flacco, Maria Elena
    Manzoli, Lamberto
    Boccia, Stefania
    Puggina, Anna
    Rosso, Annalisa
    Marzuillo, Carolina
    Scaioli, Giacomo
    Gualano, Maria Rosaria
    Ricciardi, Walter
    Villari, Paolo
    Ioannidis, John P. A.
    MAYO CLINIC PROCEEDINGS, 2016, 91 (08) : 1021 - 1034
  • [44] Off-patent drugs at brand-name prices: a puzzle for policymakers
    Tallapragada, Naren P.
    JOURNAL OF LAW AND THE BIOSCIENCES, 2016, 3 (01): : 238 - 247
  • [45] Novelty of Active Ingredients in High-Cost Brand-Name Drugs
    Emily H. Jung
    Ameet Sarpatwari
    Aaron S. Kesselheim
    Journal of General Internal Medicine, 2020, 35 : 2219 - 2221
  • [46] Medicare Formulary Coverage of Brand-Name Drugs and Therapeutically Interchangeable Generics
    Vijay, Aishwarya
    Gupta, Ravi
    Liu, Patrick
    Dhruva, Sanket S.
    Shah, Nilay D.
    Ross, Joseph S.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (06) : 1928 - 1930
  • [47] Medicare Formulary Coverage of Brand-Name Drugs and Therapeutically Interchangeable Generics
    Aishwarya Vijay
    Ravi Gupta
    Patrick Liu
    Sanket S. Dhruva
    Nilay D. Shah
    Joseph S. Ross
    Journal of General Internal Medicine, 2020, 35 : 1928 - 1930
  • [48] The bioequivalence and therapeutic efficacy of generic versus brand-name psychoactive drugs
    Borgherini, G
    CLINICAL THERAPEUTICS, 2003, 25 (06) : 1578 - 1592
  • [49] Changhong's Brand-Name Strategy
    China Today, 2000, (11) : 54 - 55
  • [50] Taste acceptability of pulverized brand-name and generic drugs containing amlodipine or candesartan
    Uestuener, Peter
    Ferrarini, Alessandra
    Santi, Maristella
    Mardegan, Chiara
    Bianchetti, Mario G.
    Simonetti, Giacomo D.
    Milani, Gregorio P.
    Lava, Sebastiano A. G.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 468 (1-2) : 196 - 198
12345